ArticleRespirology case reports2026
Primary Pulmonary Angiosarcoma: Case Report and Literature Review.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary Pulmonary Angiosarcoma: Case Report and Literature Review.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary angiosarcoma is a rare and aggressive tumour arising from the endothelial cells of the pulmonary vasculature. The average survival from time of diagnosis is 9 months. This cancer presents challenges due to small nodules, pleural effusion, and hemoptysis often being confused for benign diagnosis. We present a case of primary pulmonary angiosarcoma with similar diagnostic challenges and a rapidly declining functional status. Our patient had a non-diagnostic CT-guided lung biopsy and iliac crest bone biopsy. Definitive diagnosis was achieved by robotic navigational bronchoscopy of a 2.5 cm left lingula nodule, which identified tumour cells positive for CD31, consistent with epithelioid angiosarcoma. Despite transient improvement with supportive care, the patient's condition deteriorated, culminating in cardiac arrest and death. Our study reviews clinical courses, diagnostic tools, and treatment available for pulmonary angiosarcoma and highlights the importance of robotic biopsy as an earlier diagnostic tool for such aggressive pulmonary cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.